Calvert, A H <br/><br/>
Carboplatin and granulocyte colony-stimulating factor as first-line treatment for epithelial ovarian cancer: a phase I dose-intensity escalation study.  [electronic resource] 

 -  Seminars in oncology  Oct 1994 
 - 1-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0093-7754 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Carboplatin--adverse effects<br/>Cohort Studies<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Filgrastim<br/>Granulocyte Colony-Stimulating Factor--adverse effects<br/>Humans<br/>Leukocyte Count--drug effects<br/>Middle Aged<br/>Neoplasm Staging<br/>Ovarian Neoplasms--drug therapy<br/>Platelet Transfusion<br/>Recombinant Proteins--adverse effects<br/>Thrombocytopenia--chemically induced<br/>Treatment Outcome